end-stage renal disease (ESRD)

Passengers who travel on American Airlines from September through October 2011 will learn about the surgically implantable bioartificial kidney being developed at UCSF as a permanent solution to end stage renal disease.

Shuvo Roy, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine, Department of Bioengineering and Therapeutic Sciences, presented initial results of research into a new type of silicon-based kidney filtration membrane at the annual conference of the American Society for Artificial...

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support
Research stalwarts draw funding for decades
New directions in translational research attract support
Expansion of the School’s...

The implantable bioartificial kidney is explained in this December 6, 2010, SmartPlanet video featuring Shuvo Roy, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine.

A national research project is under way to develop an surgically implantable bioartificial kidney using the latest advances in science and technology with the goal of both improving the health and lives of patients with end stage renal disease and saving health care dollars.

The model for a surgically implantable bioartificial kidney the size of a coffee cup has been unveiled by the national project's lead researcher, Shuvo Roy, PhD, a member of the UCSF Department of Bioengineering and Therapeutic Sciences.